US EditionPublished • loading... • Updated
Recall impacts over 3.1 million eye drop products distributed nationwide: FDA
The FDA said the voluntary recall covers multiple brands after the company could not confirm the products were manufactured under sterile conditions.
- On Tuesday, March 31, 2026, the FDA disclosed that Pomona-based K.C. Pharmaceuticals voluntarily recalled 3,111,072 bottles of eye drops, prompting federal health officials to warn consumers nationwide.
- The company cited a "Lack of Assurance of Sterility" as the primary concern, meaning manufacturing processes could not guarantee prevention of infection-causing microbes.
- Products include "Artificial Tears," "Advanced Relief," and "Redness Lubricant" drops sold at major retailers CVS Health, Walgreens, Kroger, and H-E-B with lot codes starting AC, AR, LT, SU, RG, RL, SY, or AT marked 2026.
- Consumers are advised to stop using affected products immediately; health officials recommend contacting a doctor if users experience eye pain, redness, or vision changes.
- While the FDA has not outlined a formal refund process, major retailers are expected to honor returns or exchanges for identified lots pending official manufacturer instructions.
Insights by Ground AI
49 Articles
49 Articles
More than 3 million bottles of eye drops recalled over safety concerns, FDA says
A pharmaceutical company has issued a voluntary recall of over 3 million of its over-the-counter eye-drop products after the Food and Drug Administration cited a “lack of assurance of sterility.”According to the FDA notice, K.C.
·United States
Read Full Article
Coverage Details
Total News Sources49
Leaning Left8Leaning Right1Center31Last UpdatedBias Distribution78% Center
Bias Distribution
- 78% of the sources are Center
78% Center
L 20%
C 78%
Factuality
To view factuality data please Upgrade to Premium
